{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T15:45:42Z","timestamp":1765295142964,"version":"build-2065373602"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T00:00:00Z","timestamp":1628812800000},"content-version":"vor","delay-in-days":285,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infection, Genetics and Evolution"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.meegid.2020.104489","type":"journal-article","created":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T20:40:28Z","timestamp":1596487228000},"page":"104489","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Immunoinformatic construction of an adenovirus-based modular vaccine platform and its application in the design of a SARS-CoV-2 vaccine"],"prefix":"10.1016","volume":"85","author":[{"given":"Pedro Soares","family":"Porto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00e9borah","family":"Anjos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nath\u00e2nia","family":"D\u00e1billa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone Gon\u00e7alves","family":"da Fonseca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Menira","family":"Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.meegid.2020.104489_bb0005","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2174\/156652311796150372","article-title":"Adenoviral vector immunity: its implications and circumvention strategies","volume":"11","author":"Ahi","year":"2011","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.meegid.2020.104489_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00124","article-title":"Humoral responses elicited by adenovirus displaying epitopes are induced independently of the infection process and shaped by the toll-like receptor\/MyD88 pathway","volume":"9","author":"Anchim","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.meegid.2020.104489_bb0015","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-015-0245-0","article-title":"Immunoinformatics and epitope prediction in the age of genomic medicine","volume":"7","author":"Backert","year":"2015","journal-title":"Genome Med."},{"key":"10.1016\/j.meegid.2020.104489_bb0020","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/08830185.2019.1657426","article-title":"Immunoinformatics: in Silico approaches and computational design of a multi-epitope, immunogenic protein","volume":"38","author":"Bahrami","year":"2019","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.meegid.2020.104489_bb0025","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/jmv.25698","article-title":"Immunoinformatics-aided identification of T cell and B cell epitopes in the surface glycoprotein of 2019-nCoV","volume":"92","author":"Baruah","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.meegid.2020.104489_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2019.109267","article-title":"In silico rational design of a novel tetra-epitope tetanus vaccine with complete population coverage using developed immunoinformatics and surface epitope mapping approaches","volume":"130","author":"Bazmara","year":"2019","journal-title":"Med. Hypotheses"},{"author":"Brister","key":"10.1016\/j.meegid.2020.104489_bb0035"},{"key":"10.1016\/j.meegid.2020.104489_bb0040","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1186\/1471-2105-8-361","article-title":"Development of an epitope conservancy analysis tool to facilitate the design of epitope-based diagnostics and vaccines","volume":"8","author":"Bui","year":"2007","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.meegid.2020.104489_bb0045","doi-asserted-by":"crossref","DOI":"10.1007\/s40475-020-00201-6","article-title":"The SARS-CoV-2 vaccine pipeline: an overview","author":"Chen","year":"2020","journal-title":"Curr. Trop. Med. Reports."},{"key":"10.1016\/j.meegid.2020.104489_bb0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/hum.2013.2527","article-title":"Adenovirus: the first effective in vivo gene delivery vector","volume":"25","author":"Crystal","year":"2014","journal-title":"Hum. Gene Ther."},{"year":"2016","series-title":"Adenoviral Vectors for Gene Therapy","author":"Curiel","key":"10.1016\/j.meegid.2020.104489_bb0055"},{"key":"10.1016\/j.meegid.2020.104489_bb0060","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0378-1119(94)90302-6","article-title":"The penton base of human adenovirus type 3 has the RGD motif","volume":"146","author":"Cuzange","year":"1994","journal-title":"Gene"},{"key":"10.1016\/j.meegid.2020.104489_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/263952","article-title":"Prediction of IL4 inducing peptides","volume":"2013","author":"Dhanda","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.meegid.2020.104489_bb0070","doi-asserted-by":"crossref","DOI":"10.1186\/1745-6150-8-30","article-title":"Designing of interferon-gamma inducing MHC class-II binders","volume":"8","author":"Dhanda","year":"2013","journal-title":"Biol. Direct"},{"key":"10.1016\/j.meegid.2020.104489_bb0075","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1128\/JVI.80.5.2586.2006","article-title":"Comparative sequence analysis of the Hexon gene in the entire spectrum of human adenovirus serotypes: phylogenetic, taxonomic, and clinical implications","volume":"80","author":"Ebner","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2020.104489_bb0080","series-title":"Mucosal Vaccines","first-page":"419","article-title":"Recombinant Adenovirus Vectors as Mucosal Vaccines","author":"Emmer","year":"2020"},{"key":"10.1016\/j.meegid.2020.104489_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003089","article-title":"Immunization with Hexon modified adenoviral vectors integrated with gp83 epitope provides protection against Trypanosoma cruzi infection","volume":"8","author":"Farrow","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.meegid.2020.104489_bb0090","doi-asserted-by":"crossref","first-page":"W35","DOI":"10.1093\/nar\/gkn211","article-title":"PVS: a web server for protein sequence variability analysis tuned to facilitate conserved epitope discovery","volume":"36","author":"Garcia-Boronat","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.meegid.2020.104489_bb0095","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.chom.2020.03.002","article-title":"A sequence homology and Bioinformatic approach can predict candidate targets for immune responses to SARS-CoV-2","volume":"27","author":"Grifoni","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.meegid.2020.104489_bb0100","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-016-0928-3","article-title":"ProInflam: a webserver for the prediction of proinflammatory antigenicity of peptides and proteins","volume":"14","author":"Gupta","year":"2016","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.meegid.2020.104489_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01430","article-title":"IL17eScan: A tool for the identification of peptides inducing IL-17 response","volume":"8","author":"Gupta","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.meegid.2020.104489_bb0110","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.1980","article-title":"Management of adenovirus infection in patients after haematopoietic stem cell transplantation: state-of-the-art and real-life current approach","volume":"28","author":"Hiwarkar","year":"2018","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.meegid.2020.104489_bb0115","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0140-6736(06)68076-8","article-title":"Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice","volume":"367","author":"Hoelscher","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.meegid.2020.104489_bb0120","doi-asserted-by":"crossref","first-page":"10366","DOI":"10.1128\/JVI.77.19.10366-10375.2003","article-title":"Identification of adenovirus (ad) penton base neutralizing epitopes by use of sera from patients who had received conditionally replicative ad (Addl1520) for treatment of liver Tumors","volume":"77","author":"Hong","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2020.104489_bb0125","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jim.2018.01.005","article-title":"In silico identification of potential epitopes present in human adenovirus proteins for vaccine design and of putative drugs for treatment against viral infection","volume":"455","author":"Hossain","year":"2018","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.meegid.2020.104489_bb0130","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.meegid.2020.104489_bb0135","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.vaccine.2009.10.091","article-title":"Adenovirus-specific human T cells are pervasive, polyfunctional, and cross-reactive","volume":"28","author":"Hutnick","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.meegid.2020.104489_bb0140","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/imm.12889","article-title":"Improved methods for predicting peptide binding affinity to MHC class II molecules","volume":"154","author":"Jensen","year":"2018","journal-title":"Immunology"},{"key":"10.1016\/j.meegid.2020.104489_bb0145","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.4049\/jimmunol.1700893","article-title":"NetMHCpan-4.0: improved peptide\u2013MHC class I interaction predictions integrating eluted ligand and peptide binding affinity data","volume":"199","author":"Jurtz","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.meegid.2020.104489_bb0150","doi-asserted-by":"crossref","first-page":"5523","DOI":"10.1128\/JVI.02667-05","article-title":"Epitopes expressed in different adenovirus capsid proteins induce different levels of epitope-specific immunity","volume":"80","author":"Krause","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2020.104489_bb0155","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jmb.2007.05.022","article-title":"Inference of macromolecular assemblies from crystalline state","volume":"372","author":"Krissinel","year":"2007","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.meegid.2020.104489_bb0160","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.vaccine.2010.12.025","article-title":"Anti-adenovirus humoral responses influence on the efficacy of vaccines based on epitope display on adenovirus capsid","volume":"29","author":"Lanzi","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.meegid.2020.104489_bb0165","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb1469","article-title":"New coronavirus outbreak: framing questions for pandemic prevention","volume":"12","author":"Layne","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.meegid.2020.104489_bb0170","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1365-2141.2004.05218.x","article-title":"Adenovirus as an emerging pathogen in immunocompromised patients","volume":"128","author":"Leen","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.meegid.2020.104489_bb0175","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1182\/blood-2004-02-0646","article-title":"Conserved CTL epitopes on the adenovirus hexon protein expand subgroup cross-reactive and subgroup-specific CD8+ T cells","volume":"104","author":"Leen","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.meegid.2020.104489_bb0180","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1128\/JVI.01689-07","article-title":"Identification of Hexon-specific CD4 and CD8 T-cell epitopes for vaccine and immunotherapy","volume":"82","author":"Leen","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2020.104489_bb0185","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.antiviral.2016.11.006","article-title":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV","volume":"137","author":"Liu","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.meegid.2020.104489_bb0190","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1089\/hum.2013.228","article-title":"Circumventing antivector immunity: potential use of nonhuman adenoviral vectors","volume":"25","author":"Lopez-Gordo","year":"2014","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.meegid.2020.104489_bb0195","doi-asserted-by":"crossref","first-page":"W636","DOI":"10.1093\/nar\/gkz268","article-title":"The EMBL-EBI search and sequence analysis tools APIs in 2019","volume":"47","author":"Madeira","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.meegid.2020.104489_bb0200","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.meegid.2020.104489_bb0205","doi-asserted-by":"crossref","DOI":"10.1038\/srep42851","article-title":"Computer-aided designing of immunosuppressive peptides based on IL-10 inducing potential","volume":"7","author":"Nagpal","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.meegid.2020.104489_bb0210","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-018-1560-1","article-title":"Computer-aided prediction of antigen presenting cell modulators for designing peptide-based vaccine adjuvants","volume":"16","author":"Nagpal","year":"2018","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.meegid.2020.104489_bb0215","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/14760584.2020.1711054","article-title":"The potential of adenoviral vaccine vectors with altered antigen presentation capabilities","volume":"19","author":"Neukirch","year":"2020","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.meegid.2020.104489_bb0220","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jtbi.2014.01.018","article-title":"A novel multi-epitope peptide vaccine against cancer: An in silico approach","volume":"349","author":"Nezafat","year":"2014","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.meegid.2020.104489_bb0225","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1099\/vir.0.82867-0","article-title":"The CD4+ T-cell response to adenovirus is focused against conserved residues within the hexon protein","volume":"88","author":"Onion","year":"2007","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.meegid.2020.104489_bb0230","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.vaccine.2010.12.040","article-title":"Adenovirus particles that display the plasmodium falciparum circumsporozoite protein NANP repeat induce sporozoite-neutralizing antibodies in mice","volume":"29","author":"Palma","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.meegid.2020.104489_bb0235","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF chimera?A visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.meegid.2020.104489_bb0240","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/jmv.21571","article-title":"Characterization of cytotoxic T-lymphocyte epitopes and immune responses to SARS coronavirus spike DNA vaccine expressing the RGD-integrin-binding motif","volume":"81","author":"Poh","year":"2009","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.meegid.2020.104489_bb0245","article-title":"Dysregulation of immune response in patients with COVID-19 in Wuhan, China","author":"Qin","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.meegid.2020.104489_bb0250","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3855\/jidc.12425","article-title":"2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness","volume":"14","author":"Ralph","year":"2020","journal-title":"J. Infect. Dev. Ctries."},{"key":"10.1016\/j.meegid.2020.104489_bb0255","doi-asserted-by":"crossref","DOI":"10.1038\/srep01812","article-title":"Molecular evolution of human adenoviruses","volume":"3","author":"Robinson","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.meegid.2020.104489_bb0260","doi-asserted-by":"crossref","first-page":"9553","DOI":"10.1128\/JVI.77.17.9553-9566.2003","article-title":"Structural and phylogenetic analysis of adenovirus Hexons by use of high-resolution X-ray crystallographic, molecular modeling, and sequence-based methods","volume":"77","author":"Rux","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2020.104489_bb0265","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/prot.21078","article-title":"Prediction of continuous B-cell epitopes in an antigen using recurrent neural network","volume":"65","author":"Saha","year":"2006","journal-title":"Proteins Struct. Funct. Bioinforma."},{"key":"10.1016\/j.meegid.2020.104489_bb0270","doi-asserted-by":"crossref","DOI":"10.1007\/s10989-019-10003-8","article-title":"Exploring Lassa virus proteome to design a multi-epitope vaccine through Immunoinformatics and immune simulation analyses","author":"Sayed","year":"2020","journal-title":"Int. J. Pept. Res. Ther."},{"key":"10.1016\/j.meegid.2020.104489_bb0275","series-title":"Adenoviral Vectors for Gene Therapy","first-page":"571","article-title":"Adenoviral Vectors Vaccine","author":"Sharma","year":"2016"},{"key":"10.1016\/j.meegid.2020.104489_bb0280","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1128\/JVI.79.2.1053-1061.2005","article-title":"Deletion of penton RGD motifs affects the efficiency of both the internalization and the endosome escape of viral particles containing adenovirus serotype 5 or 35 Fiber knobs","volume":"79","author":"Shayakhmetov","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2020.104489_bb0285","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.1172\/JCI39812","article-title":"Replacing adenoviral vector HVR1 with a malaria B cell epitope improves immunogenicity and circumvents preexisting immunity to adenovirus in mice","volume":"120","author":"Shiratsuchi","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.meegid.2020.104489_bb0290","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1128\/JVI.78.6.2666-2673.2004","article-title":"Neutralizing antibodies and CD8+ T lymphocytes both contribute to immunity to adenovirus serotype 5 vaccine vectors","volume":"78","author":"Sumida","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2020.104489_bb0295","doi-asserted-by":"crossref","first-page":"7179","DOI":"10.4049\/jimmunol.174.11.7179","article-title":"Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein","volume":"174","author":"Sumida","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.meegid.2020.104489_bb0300","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02462-16","article-title":"Recombinant adenoviruses displaying matrix 2 Ectodomain epitopes on their Fiber proteins as universal influenza vaccines","volume":"91","author":"Tang","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2020.104489_bb0305","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1128\/CVI.00207-14","article-title":"Hexon Hypervariable region-modified adenovirus type 5 (Ad5) vectors display reduced hepatotoxicity but induce T lymphocyte phenotypes similar to Ad5 vectors","volume":"21","author":"Teigler","year":"2014","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.meegid.2020.104489_bb0310","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-016-1042-2","article-title":"Discovery of immunodominant T-cell epitopes reveals penton protein as a second immunodominant target in human adenovirus infection","volume":"14","author":"Tischer","year":"2016","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.meegid.2020.104489_bb0315","doi-asserted-by":"crossref","first-page":"5156","DOI":"10.1128\/JVI.73.6.5156-5161.1999","article-title":"RGD inclusion in the hexon monomer provides adenovirus type 5-based vectors with a fiber knob-independent pathway for infection","volume":"73","author":"Vigne","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2020.104489_bb0320","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3390\/biomedicines6030081","article-title":"Progress in adenoviral capsid-display vaccines","volume":"6","author":"Vujadinovic","year":"2018","journal-title":"Biomedicines"},{"year":"2020","series-title":"World Health Organization","author":"WHO, W.H. organization","key":"10.1016\/j.meegid.2020.104489_bb0325"},{"key":"10.1016\/j.meegid.2020.104489_bb0330","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1021\/acs.molpharmaceut.8b00591","article-title":"Capsid-incorporation strategy to display antigens for an alternative adenoviral vector vaccine approach","volume":"15","author":"van Winkel","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.meegid.2020.104489_bb0335","first-page":"eabb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","author":"Wrapp","year":"2020","journal-title":"Science (80-. )"},{"key":"10.1016\/j.meegid.2020.104489_bb0340","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.meegid.2020.104489_bb0345","doi-asserted-by":"crossref","DOI":"10.1186\/s12985-015-0364-7","article-title":"Capsid display of a conserved human papillomavirus L2 peptide in the adenovirus 5 hexon protein: a candidate prophylactic hpv vaccine approach","volume":"12","author":"Wu","year":"2015","journal-title":"Virol. J."},{"key":"10.1016\/j.meegid.2020.104489_bb0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12985-015-0364-7","article-title":"Capsid display of a conserved human papillomavirus L2 peptide in the adenovirus 5 hexon protein: a candidate prophylactic hpv vaccine approach","volume":"12","author":"Wu","year":"2015","journal-title":"Virol. J."},{"key":"10.1016\/j.meegid.2020.104489_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2020.03.004","article-title":"The SARS-CoV-2 outbreak: what we know","author":"Wu","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.meegid.2020.104489_bb0360","article-title":"The deadly coronaviruses: the 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China","volume":"102434","author":"Yang","year":"2020","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.meegid.2020.104489_bb0365","doi-asserted-by":"crossref","first-page":"12125","DOI":"10.1128\/JVI.79.19.12125-12131.2005","article-title":"Adenovirus Receptors","volume":"79","author":"Zhang","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2020.104489_bb0370","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/mt.2012.248","article-title":"Hexon-modified recombinant E1-deleted adenovirus vectors as dual specificity vaccine carriers for influenza virus","volume":"21","author":"Zhou","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.meegid.2020.104489_bb0375","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.molcel.2004.11.041","article-title":"The structure of the human adenovirus 2 penton","volume":"17","author":"Zubieta","year":"2005","journal-title":"Mol. Cell"}],"container-title":["Infection, Genetics and Evolution"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134820303208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134820303208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T14:55:44Z","timestamp":1761576944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567134820303208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":75,"alternative-id":["S1567134820303208"],"URL":"https:\/\/doi.org\/10.1016\/j.meegid.2020.104489","relation":{},"ISSN":["1567-1348"],"issn-type":[{"type":"print","value":"1567-1348"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunoinformatic construction of an adenovirus-based modular vaccine platform and its application in the design of a SARS-CoV-2 vaccine","name":"articletitle","label":"Article Title"},{"value":"Infection, Genetics and Evolution","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.meegid.2020.104489","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104489"}}